REGULATION OF HIV-1 RNA SPLICING

HIV-1 RNA 剪接的调控

基本信息

  • 批准号:
    2072130
  • 负责人:
  • 金额:
    $ 17.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-01-01 至 1998-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Adapted from investigator's abstract) The goal of this project is to understand the regulation of HIV RNA splicing in terms of positive and negative cis elements within the viral genome and the role of cellular regulatory proteins which interact with these elements.The proposed studies will focus on the regulation by cellular factors of HIV RNA splicing in the regions including and flanking the first and second coding exons of the HIV tat (transactivator) and rev genes.The first specific aim is to define further cis-acting RNA splicing elements in the HIV first tat coding exon. The investigator will use in vitro splicing assays with HIV RNA substrates and analysis of HIV RNA in cells transiently transfected with mutant proviral clones to further define this element. The replication phenotype of virus containing mutations in he splicing element will also be studied. The second aim is to identify and characterize cellular RNA-binding factors interacting with the negative splicing regulatory element. Evidence for the presence of a factor or factors that bind to the negative splicing regulatory element in the first tat coding exon has been obtained. This factor(s) will be characterized and, if it a novel factor, the gene will be cloned and sequenced. The third goal is to define cis-acting positive and negative splicing elements in the second tat/rev coding exon. Elements will be defined using in vitro splicing assays and transient transfections.If novel factors bind to these elements, the genes will be cloned and sequenced.
描述:(改编自研究者的摘要)这个的目的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brad Amendt其他文献

Brad Amendt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brad Amendt', 18)}}的其他基金

Training in Molecular Virology and Viral Pathogenesis
分子病毒学和病毒发病机制培训
  • 批准号:
    7101880
  • 财政年份:
    1998
  • 资助金额:
    $ 17.5万
  • 项目类别:
TRAINING IN MOLECULAR VIROLOGY AND VIRAL PATHOGENESIS
分子病毒学和病毒发病机制培训
  • 批准号:
    2653779
  • 财政年份:
    1998
  • 资助金额:
    $ 17.5万
  • 项目类别:
TRAINING IN MOLECULAR VIROLOGY AND VIRAL PATHOGENESIS
分子病毒学和病毒发病机制培训
  • 批准号:
    6372845
  • 财政年份:
    1998
  • 资助金额:
    $ 17.5万
  • 项目类别:
TRAINING IN MOLECULAR VIROLOGY AND VIRAL PATHOGENESIS
分子病毒学和病毒发病机制培训
  • 批准号:
    6169085
  • 财政年份:
    1998
  • 资助金额:
    $ 17.5万
  • 项目类别:
Training in Molecular Virology and Viral Pathogenesis
分子病毒学和病毒发病机制培训
  • 批准号:
    7274712
  • 财政年份:
    1998
  • 资助金额:
    $ 17.5万
  • 项目类别:
Training in Molecular Virology and Viral Pathogenesis
分子病毒学和病毒发病机制培训
  • 批准号:
    6937660
  • 财政年份:
    1998
  • 资助金额:
    $ 17.5万
  • 项目类别:
TRAINING IN MOLECULAR VIROLOGY AND VIRAL PATHOGENESIS
分子病毒学和病毒发病机制培训
  • 批准号:
    6510144
  • 财政年份:
    1998
  • 资助金额:
    $ 17.5万
  • 项目类别:
Training in Molecular Virology and Viral Pathogenesis
分子病毒学和病毒发病机制培训
  • 批准号:
    7470650
  • 财政年份:
    1998
  • 资助金额:
    $ 17.5万
  • 项目类别:
TRAINING IN MOLECULAR VIROLOGY AND VIRAL PATHOGENESIS
分子病毒学和病毒发病机制培训
  • 批准号:
    2886254
  • 财政年份:
    1998
  • 资助金额:
    $ 17.5万
  • 项目类别:
Training in Molecular Virology and Viral Pathogenesis
分子病毒学和病毒发病机制培训
  • 批准号:
    6801237
  • 财政年份:
    1998
  • 资助金额:
    $ 17.5万
  • 项目类别:

相似海外基金

The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
  • 批准号:
    23K15977
  • 财政年份:
    2023
  • 资助金额:
    $ 17.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an efficient method combining quantum chemistry and machine learning to evolve PCR technology and gene mutation analysis
开发一种结合量子化学和机器学习的有效方法来发展 PCR 技术和基因突变分析
  • 批准号:
    22KJ2450
  • 财政年份:
    2023
  • 资助金额:
    $ 17.5万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of preemptive medicine for asymptomatic MEN1 gene mutation carriers
无症状MEN1基因突变携带者的抢先治疗药物开发
  • 批准号:
    23H03151
  • 财政年份:
    2023
  • 资助金额:
    $ 17.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of molecular mechanisms of occurrence of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
  • 批准号:
    23K08067
  • 财政年份:
    2023
  • 资助金额:
    $ 17.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular mechanism of maxillofacial hypoplasia caused by FAT1 gene mutation
FAT1基因突变引起颌面发育不全的分子机制阐明
  • 批准号:
    22K19629
  • 财政年份:
    2022
  • 资助金额:
    $ 17.5万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Association between CD79B gene mutation and prognosis in vitreoretinal lymphoma
CD79B基因突变与玻璃体视网膜淋巴瘤预后的关系
  • 批准号:
    22K09763
  • 财政年份:
    2022
  • 资助金额:
    $ 17.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gene mutation/expression prediction from clinical images using artificial intelligence technology in pancreatic cancer
利用人工智能技术从临床图像预测胰腺癌基因突变/表达
  • 批准号:
    20K17570
  • 财政年份:
    2020
  • 资助金额:
    $ 17.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of colorectal carcinogenesis mediated by PTPRK gene mutation
PTPRK基因突变介导的结直肠癌发生机制的阐明
  • 批准号:
    20K16311
  • 财政年份:
    2020
  • 资助金额:
    $ 17.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the molecular mechanism of development of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
  • 批准号:
    20K08953
  • 财政年份:
    2020
  • 资助金额:
    $ 17.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of next-generation precision medicine targeting the pathways on which driver gene mutation-positive lung cancer depends
针对驱动基因突变阳性肺癌所依赖的途径开发下一代精准医疗
  • 批准号:
    20H03771
  • 财政年份:
    2020
  • 资助金额:
    $ 17.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了